dabigatran has been researched along with Heavy Menstrual Bleeding in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Last-Koopmans, S; Mooij, R; Neeteson, M | 1 |
| Baldwin, MK; Chi, V; Edelman, AB; McCarty, OJT; Samuelson Bannow, BT; Sochacki, P | 1 |
| Ferreira, M; Feuring, M; Fraessdorf, M; Huisman, MV; Klok, FA | 1 |
3 other study(ies) available for dabigatran and Heavy Menstrual Bleeding
| Article | Year |
|---|---|
[Increased menstrual bleeding among direct oral anticoagulant users].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Menorrhagia; Middle Aged; Rivaroxaban | 2023 |
Heavy menstrual bleeding in women on oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Menorrhagia; Pyridones; Retrospective Studies; Rivaroxaban | 2021 |
Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism.
Topics: Adolescent; Adult; Anticoagulants; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Dabigatran; Factor Xa Inhibitors; Female; Humans; Incidence; Menorrhagia; Middle Aged; Multicenter Studies as Topic; Uterine Hemorrhage; Venous Thromboembolism; Vitamin K; Warfarin; Young Adult | 2018 |